Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement
A new study compares edoxaban anticoagulant with the standard of care in large randomized clinical trial.
from Latest Science News -- ScienceDaily https://ift.tt/3Bmxy1h
from Latest Science News -- ScienceDaily https://ift.tt/3Bmxy1h
Comments
Post a Comment